HedgePath Pharmaceuticals, Inc.·4

Dec 26, 5:15 PM ET

MAGRAB E. BRENDAN 4

4 · HedgePath Pharmaceuticals, Inc. · Filed Dec 26, 2018

Insider Transaction Report

Form 4
Period: 2018-12-20
MAGRAB E. BRENDAN
DirectorChairman of the Board
Transactions
  • Award

    Common Stock

    2018-12-20$0.08/sh+65,000$5,20065,000 total

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION